Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

AG-636 for the Treatment of Adults with Advanced Lymphoma: Initiation of a Phase 1 Clinical Study

Scott F. Huntington, MD MPH, Avyakta Kallam, MD, Frank G. Basile, MD, Danielle Ulanet, Huansheng Xu, PhD, Feng Yin, PhD, Michelle Mobilia, BS, Michael Cooper, MD, Bijal Shah, MD, John P. Leonard, MD, Gottfried R. von Keudell, MD PhD, Ajay K. Gopal, MD

Blood (2019) 134 (Supplement_1): 1286.

https://doi.org/10.1182/blood-2019-123420

Published: 2019

Journal Articles

Impact of Creatinine Clearance in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP : A Real-World Long-Term Observation Analysis at a Single Institute

Noriko Nishimura, MD PhD, Takanori Fukuta, MD, Anna Nishihara, MD, Yuko Shirouchi, MD, Hideki Uryu, MD, Norihito Inoue, MD, Yoshiharu Kusano, MD, Naoko Tsuyama, MD PhD, Kengo Takeuchi, MD PhD, Yuko Mishima, MD PhD, Masahiro Yokoyama, MD, Yasuhito Terui, MD PhD

Blood (2018) 132 (Supplement 1): 5399.

https://doi.org/10.1182/blood-2018-99-115897

Published: 2018

Journal Articles

Multiple Myeloma in Russia (First Results of the Registration Trial)

Larisa P. Mendeleeva, MD PhD Prof, Maxim V. Solovev, MD, Anna Alexeeva, Ochsana Ochirova, Naida Baygishieva, Imisa Baygishieva, Svetlana Beliaeva, Tatiana V Shelekhova, Varvara Bogova, Elena Borisenkova, Irina Verkhoglyad, Valentine Molostvova, Elena Volodicheva, MD, Elena Voronova, Valery Lapin, Elena Gribanova, Taras Gritsenko, MD, Igor Davydkin, MD PhD, Olga Dianova, Marina Kosinova, Yury Dunaev, MD, Natalia Esefyeva, Ekaterina Zotina, Anna Zarubina, Elena Kirillova, Ekaterina Kalinovskay, Yana Tsinchenko, Kamil D Kaplanov, Mariya Shirokova, Taniana Kaporskaia, Marina Kiseleva, Marina Kozmina, Tatiana Konstantinova, Ekaterina Krupkina, Elena Kuznetcova, Guzaliya Gaynullina, Ekaterina Lisina, Natalia Mashnina, Svetlana Osjnihina, Svetlana Menshikova, Mikhail Mikhalev, Olga Samoilova, Dmitry Morozov, Islam Nakastoev, MD, Maria Novikova, Zhanna Davydova, Elena Patrakova, Natalya Popova, Natalia Rachkova, Irina Rekhtina, Marina Savinova, Tatiana Pospelova, Natalia Skvortsova, Irina Sokolova, Nadezhda Stepanova, Tatyana Sycheva, Elena Tarasenko, Ekaterina Filatova, Valeriy Voytsekhovskiy, Lyudmila Anchukova, Maria Frolova, Anna Khazieva, Elena Martynova, Evgeniy Vasiliev, Tatyana Ksenzova, Ilmil Shackirov, Valery Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 5408.

https://doi.org/10.1182/blood.V130.Suppl_1.5408.5408

Published: 2017

Journal Articles

Superior Efficacy of Carfilzomib and Dexamethasone (Kd56) Vs Bortezomib and Dexamethasone (Vd) in Multiple Myeloma (MM) Patients with Moderate or Serious Renal Failure: A Subgroup Analysis of the Phase 3 Endeavor Study

Meletios A. Dimopoulos, David Siegel, MD PhD, Darrell J. White, MD, Ralph V. Boccia, Zhao Yang, Amy S. Kimball, Karim Saad Iskander, Khalid Mezzi, MD MBA, Heinz Ludwig, MD, Ruben Niesvizky, MD

Blood (2017) 130 (Supplement 1): 1845.

https://doi.org/10.1182/blood.V130.Suppl_1.1845.1845

Published: 2017

Journal Articles

Assessment of Bone Marrow Function in Sickle Cell Anaemia Patients Using Corrected Reticulocyte Counts

Titilola S. Akingbola, MBBS, FWACP, Chinedu Anthony Ezekekwu, MBBS, Joseph Yaria, MBBS, Santosh L. Saraf, MD, Lewis L. Hsu, MD PhD, Richard S. Cooper, MD, Victor R. Gordeuk, MD, Bamidele O. Tayo, PhD

Blood (2015) 126 (23): 4581.

https://doi.org/10.1182/blood.V126.23.4581.4581

Published: 2015

Journal Articles

Use Of Fondaparinux For Venous Thromboembolism Prophylaxis In Critically Ill Adult Patients With Moderate Renal Insufficiency

Anjan J Patel, MD, Marc Zumberg, MD, Jessica Cope, PharmD, Jennifer Bushwitz, PharmD, Abigail D Antigua, PharmD

Blood (2013) 122 (21): 4806.

https://doi.org/10.1182/blood.V122.21.4806.4806

Published: 2013

Journal Articles

Pomalidomide (POM) with Low-Dose Dexamethasone (LoDEX) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Impact of Renal Function on Patient Outcomes

David S. Siegel, MD, PhD, Paul G. Richardson, MD, Rachid Baz, MD, Min Chen, PhD, Mohamed Zaki, MD, Kenneth C. Anderson, MD

Blood (2012) 120 (21): 4072.

https://doi.org/10.1182/blood.V120.21.4072.4072

Published: 2012

Journal Articles

Pharmacokinetics (PK) of Lenalidomide When Administered Alone or in Combination with Dexamethasone in Chinese Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): The MM-021 Trial

Nianhang Chen, PhD, Dao-bin Zhou, MD, Li Yu, Jay Mei, MD, PhD, Liangang Liu, Xiaomin Wang, Honeylet Wortman-Vayn, Jian Hou, MD, PhD

Blood (2012) 120 (21): 5046.

https://doi.org/10.1182/blood.V120.21.5046.5046

Published: 2012

Journal Articles

A Randomized Phase 2 Trial of Bortezomib–Dexamethasone Versus Bortezomib–Dexamethasone with Added Cyclophosphamide or Lenalidomide in Multiple Myeloma Patients Achieving Stable Disease After Four Cycles of Bortezomib–Dexamethasone Administered as Second-Line Treatment.

Meletios A. Dimopoulos, Huw Roddie, Meral Beksac, Lotfi Benboubker, Romualdas Jurgutis, Christian Langer, Javier de la Rubia, Luis Felipe Casado, Kazimierz Kuliczkowski, Lena Macukanovic-Golubovic, Thierry Facon

Blood (2009) 114 (22): 4937.

https://doi.org/10.1182/blood.V114.22.4937.4937

Published: 2009

Journal Articles

Bortezomib (VEL) Based Regimens in Multiple Myeloma (MM) Patients with Renal Impairment (RI): A Preliminary Retrospective Italian Multicenter Study

Blood (2008) 112 (11): 3681.

https://doi.org/10.1182/blood.V112.11.3681.3681

Published: 2008

Journal Articles

Impact of Baseline Renal Function on Transfusion-Independence Response, Survival, and Transformation to Acute Myeloid Leukemia in Patients with Deletion 5q: A Sub-Analysis of the MDS-003 Study

Minoo Battiwalla, MD, Tommy Fu, Robert D. Knight, MD, Alan F. List, MD

Blood (2008) 112 (11): 5088.

https://doi.org/10.1182/blood.V112.11.5088.5088

Published: 2008

Journal Articles

Frequency of “Special Population” Characteristics among Venous Thromboembolism Patients in Clinical Practice: Implications for Anticoagulant Therapy.

Lauren Cook, Susan R. Kahn, MD MSc, Jodi Goodwin, Michael J. Kovacs, MD

Blood (2006) 108 (11): 4112.

https://doi.org/10.1182/blood.V108.11.4112.4112

Published: 2006

NARROW

AG-636 for the Treatment of Adults with Advanced Lymphoma: Initiation of a Phase 1 Clinical Study

Impact of Creatinine Clearance in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP : A Real-World Long-Term Observation Analysis at a Single Institute

Multiple Myeloma in Russia (First Results of the Registration Trial)

Superior Efficacy of Carfilzomib and Dexamethasone (Kd56) Vs Bortezomib and Dexamethasone (Vd) in Multiple Myeloma (MM) Patients with Moderate or Serious Renal Failure: A Subgroup Analysis of the Phase 3 Endeavor Study

Assessment of Bone Marrow Function in Sickle Cell Anaemia Patients Using Corrected Reticulocyte Counts

Use Of Fondaparinux For Venous Thromboembolism Prophylaxis In Critically Ill Adult Patients With Moderate Renal Insufficiency

Pomalidomide (POM) with Low-Dose Dexamethasone (LoDEX) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Impact of Renal Function on Patient Outcomes

Pharmacokinetics (PK) of Lenalidomide When Administered Alone or in Combination with Dexamethasone in Chinese Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): The MM-021 Trial

A Randomized Phase 2 Trial of Bortezomib–Dexamethasone Versus Bortezomib–Dexamethasone with Added Cyclophosphamide or Lenalidomide in Multiple Myeloma Patients Achieving Stable Disease After Four Cycles of Bortezomib–Dexamethasone Administered as Second-Line Treatment.

Bortezomib (VEL) Based Regimens in Multiple Myeloma (MM) Patients with Renal Impairment (RI): A Preliminary Retrospective Italian Multicenter Study

Impact of Baseline Renal Function on Transfusion-Independence Response, Survival, and Transformation to Acute Myeloid Leukemia in Patients with Deletion 5q: A Sub-Analysis of the MDS-003 Study

Frequency of “Special Population” Characteristics among Venous Thromboembolism Patients in Clinical Practice: Implications for Anticoagulant Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only